I think this comes down to the company's tolerance for risk. I recently considered the 513(g) in this situation, but I just didn't see how it was worth the time and money just to gain confidence. Neither did my client.
I think in your situation the only other option would be a De novo? In that case, I'm more inclined to be "in for a penny, in for a pound." Either take the risk or don't take the risk, rather than trying to take it, but not really.
I chose to focus more on identifying and mitigating risks you would exposed to if you choose to go on the market as 510(k) exempt, but don't seek FDA confirmation, and then some day FDA comes along and shares its unsolicited opinion with you. My client was comfortable with this approach, which might or might not be comfortable for you, depending on a variety of factors.
------------------------------
Julie Omohundro, ex-RAC (US, GS), still an MBA
Principal Consultant
Class Three, LLC
Durham, North Carolina, USA
919-544-3366 (T)
434-964-1614 (C)
julie@class3devices.com
Original Message:
Sent: 26-Oct-2016 15:46
From: Julie Broderick
Subject: Experiences with 510(k) Exemption & 513(g) Requests
I would like to ask for the help of RAPS Forum members in their experiences with the following:
1. Use of the 510(k) exemption pathway for a new product from a new manufacturer (not just a line extension or modified product from an existing manufacturer where you are confident that the product is 510(k) exempt). If you determined that a device was exempt and could be marketed without a 510(k), how confident were you that the product met the generic device description in the product classification regulation? How did you document this? Were you concerned about any slight differences between the new device and the generic description? What is your perception of the risk in this approach?
2. Use of the 513(g) request process to support #1. If you filed a 513(g) request regarding whether a particular product fit the product classification regulation, did you get a confirmatory response from FDA? Was this process helpful in gaining confidence about using the 510(k) exemption pathway?
Thanks in advance for any help you can provide!
------------------------------
Julie Broderick RAC
Broderick Regulatory Consulting, LLC
Winchester MA
United States
------------------------------